| abstract |
It is intended to provide agents improving the lipid metabolism in the liver. This object is achieved by providing lipid metabolism improving agents containing an enzymatic digestion product of soybean protein whereby the triglyceride content in the liver can be lowered and the secretion of triglycerides in the liver can be inhibited. By using the above agents, β-oxidation in the liver can be accelerated, i.e., the digestion of fatty acids can be accelerated and thus fat accumulated as body fat is consumed, thereby achieving an effect of lessening body fat. |